Bibliothek

Sprache
Bevorzugter Suchindex
Ergebnisse pro Seite
Sortieren nach
Sortierung
Anzahl gespeicherter Suchen in der Suchhistorie
E-Mail-Adresse
Voreingestelltes Exportformat
Voreingestellte Zeichencodierung für Export
Anordnung der Filter
Maximale Anzahl angezeigter Filter
Autovervollständigung
Feed-Format
Anzahl der Ergebnisse pro Feed
feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • 1
    ISSN: 1432-1203
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Biologie , Medizin
    Notizen: Abstract Congenital heart disease (CHD) affects over 40% of Down syndrome (DS) patients. The region proposed to contain the gene(s) for DS CHD has been restricted to 21q22.2–22.3, from D21S55 to MX1. The identification and functional characterization of the genes mapping to this region is a necessary step to understand the pathogenesis of CHD in DS. In an effort to contribute to the construction of a transcriptional map of the DS CHD region we have performed direct cDNA selection using a YAC contig that maps between ETS2 and D21S15 and cDNAs synthetised from fetal heart structures. Here we describe the identification and characterization of a new gene, WRB, that maps to 21q22.3 between ACTL5 and HMG 14 and appears to be widely expressed in adult and fetal tissues. The new gene encodes a basic protein of unknown function containing a tryptophan-rich carboxyl-terminal region and a potential nuclear localization signal. Immunofluorescence analysis shows a predominant localization in the cell nucleus. The understanding of the biological function of the protein product should clarify the potential role of WRB in the pathogenesis of DS CHD.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    ISSN: 1573-5044
    Schlagwort(e): alkaloids ; Amaryllidaceae ; Narcissus confusus ; galanthamine ; in vitro organ culture ; sucrose
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Biologie
    Notizen: Abstract In order to produce galanthamine, an alkaloid currently being tested in Alzheimer's disease therapy, we have used in vitro organ cultures of Narcissus confusus (Amaryllidaceae) plants starting from two different explants: double scale segments with basal plate from bulbs (organogenic cultures), and mature seeds (callogenic-organogenic cultures). Shoot-clumps were induced from buds obtained from twin-scales and from organogenic calluses on a MS medium supplemented with 1 mg l−1 2,4-D and 5 mg l−1 BA. Shoot-clumps were then developed partially submerged in a liquid medium. After one month of precondition, the shoot-clumps were cultured in liquid media with different concentrations of sucrose, from 3% to 18% (w/v) for 14 days. The growth of the regenerated plants treated with 9% sucrose was significantly greater. Under a photoperiod 16 h light/8 h dark, the shoot-clump cultures subjected to the two highest sucrose concentrations gave rise to higher dry weight/fresh weight ratios. Different doses of sucrose affected not only the alkaloid profile in the shoot-clump tissues but also that excreted to the medium. In all cases, shoot cultures of N. confusus were capable of galanthamine biosynthesis, with the best results at 9% sucrose concentration.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...